The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.

Rapid vaccinations, progress on vaccines and expanded stimulus continued to drive stocks higher; the USA is expected to become the engine of the global economy this year. Here, 5 ETFs that should continue to outperform should these trends prevail.

Wall Street has been enjoying continued ascent with the S&P 500 and Dow Jones hitting a series of record highs.

Novavax NVAX is a formidable name on the list of companies, which are developing a COVID-19 vaccine. Here are a few ETFs that are exposed to Novavax, which was up around 22% in after-hour trading after the announcement of encouraging vaccine data.

The first company to begin human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has once again come up with encouraging study data relating to mRNA-1273.